What is the catalog number for Cyclin D1/CCND1 Rabbit Polyclonal Antibody?

The catalog number for Cyclin D1/CCND1 Rabbit Polyclonal Antibody is orb180681.

What sizes are available for Cyclin D1/CCND1 Rabbit Polyclonal Antibody?

Cyclin D1/CCND1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Cyclin D1/CCND1 Rabbit Polyclonal Antibody in stock?

Cyclin D1/CCND1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Cyclin D1/CCND1 Rabbit Polyclonal Antibody

Anti-Cyclin D1/CCND1 Antibody. Tested in Flow Cytometry, WB applications. This antibody reacts with Human, Rat.

Product Specifications

Product Name Alternative

G1/S-specific cyclin-D1; B-cell lymphoma 1 protein; BCL-1; BCL-1 oncogene; PRAD1 oncogene; CCND1; BCL1, PRAD1

UniProt

P24385

Reactivity

Human, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the N-terminus of human Cyclin D1, different from the related mouse and rat sequences by two amino acids.

Target

G1/S-specific cyclin-D1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Rat Flow Cytometry (Fixed), 1-3μg/1x10^6 cells, Human

Form

Lyophilized

Molecular Weight

33 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.